Table 1.
Reference | Sample type | Biomarker type | Detection method | Number of cases | Sensitivity/specificity (%) |
---|---|---|---|---|---|
Halling et al15 | Bronquial brushing | Cytology and chromosomal abnormailities | Combined cytology and FISH | Patients = 89 | 75/83 |
Bronquial washing | Controls = 48a | 61/95 | |||
Spira et al20 | Bronquial brushing | Gene expression | Microarrays | Primary dataset | |
Patients = 60 | 80/84 | ||||
Controls = 69a | |||||
Validation dataset | |||||
Patients = 18 | 83/76 | ||||
Controls = 17a | |||||
Sozzi et al24 | Blood | DNA | PCR | Patients = 100 | 90/86b |
Controls = 100 | |||||
Tanaka et al38 | Blood | CTC | CTC count | Patients = 125 | 30.4/88.0c |
Controls = 25a | |||||
Patz et al79 | Serum | Proteins | ELISA | Primary dataset | |
Patients = 50 | 89.3/84.7 | ||||
Controls = 50 | |||||
Validation dataset | |||||
Patients = 49 | 77.8/75.4 | ||||
Controls = 48 | |||||
Miura et al66 | Serum | Gene expression | RT-PCR | Patients = 112 | 89/72d |
Controls = 80 | 71/80e | ||||
Zheng et al33 | Plasma | microRNas | RT-PCR | Patients = 74 | 81.33/86.76 |
Controls = 68 | |||||
Jantus-Lewintre et al83 | Plasma | Proteins | ELISA | Patients = 432 | 74.5/85.7 |
Control = 89 | |||||
Showe et al36 | PBMC | Gene expression | Arrays | Primary dataset | |
Patients = 137 | 91/80 | ||||
Controls = 91a | |||||
Validation dataset | |||||
Patients = 38 | 76/82 | ||||
Controls = 17a | |||||
Yu et al53 | Sputum | microRNas | RT-PCR | Primary dataset | |
Patients = 36 | 80.6/91.7 | ||||
Controls = 36 | |||||
Validation dataset | |||||
Patients = 64 | 70.3/80 | ||||
Controls = 58 | |||||
Xie et al52 | Sputum | microRNas | RT-PCR | Patients = 23 | 69.7/100 |
Controls = 17a |
Notes:
Control group consisted of patients without lung cancer;
Highest value obtained with a DNA concentration value of 9 ng/mL;
Cut-off CTC count ≥ 1;
Obtained with hTERT;
Obtained with EGFR.
Abbreviations: CTC, circulating tumor cell; EGFR, epidermal growth factor receptor; ELISA, enzyme-linked immunosorbent assay; FISH, fluorescence in situ hybridization; hTERT, human telomerase reverse transcriptase gene; PBMC, peripheral blood mononuclear cells; PCR, polymerase chain reaction; RT-PCR, real-time polymerase chain reaction.